![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
SE Abraham, MC Carter and E Moran
Cold Spring Harbor Laboratory, New York 11724.
We have used E1A probes to study the roles of the p34cdc2 kinase and the retinoblastoma tumor susceptibility gene product (pRB) in transforming growth factor beta 1 (TGF beta 1)-mediated growth suppression in mink lung epithelial (Mv1Lu) cells. In agreement with previous reports, we see a decline in p34cdc2 kinase activity and a loss of pRB phosphorylation after TGF beta 1 treatment. We report here that TGF beta 1 induces not only a change in p34cdc2 kinase activity but a strong repression of p34cdc2 synthesis. Loss of p34cdc2 kinase activity is not seen until the steady-state level of p34cdc2 declines, suggesting that the intra-cellular signals induced by TGF beta 1 affect p34cdc2 at the level of expression, rather than by altering the posttranslational modifications of p34cdc2 that regulate its kinase activity. Infection with adenovirus expressing either wild-type E1A or a mutant E1A (pm928) defective for pRB binding alleviated TGF beta 1- mediated suppression of DNA synthesis, indicating that E1A does not need to bind pRB physically to keep cell growth-suppressing functions from being activated by TGF beta 1. The E1A.928 mutant virus is able to maintain p34cdc2 expression and kinase activity, as well as pRB phosphorylation in the presence of TGF beta 1, which may account for its ability to maintain cell cycle activity without directly sequestering pRB. Overall our results suggest that TGF beta 1 acts by signaling changes at the level of control of G1 gene expression, not at the level of posttranslational modification of p34cdc2 or its substrates.
This article has been cited by other articles:
|
|
 |
|
  T. Takebayashi, H. Higashi, H. Sudo, H. Ozawa, E. Suzuki, O. Shirado, H. Katoh, and M. Hatakeyama NF-kappa B-dependent Induction of Cyclin D1 by Retinoblastoma Protein (pRB) Family Proteins and Tumor-derived pRB Mutants J. Biol. Chem., April 18, 2003; 278(17): 14897 - 14905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Helt and D. A. Galloway Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins Carcinogenesis, February 1, 2003; 24(2): 159 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. PIEK, C.-H. HELDIN, and P. TEN DIJKE Specificity, diversity, and regulation in TGF-{beta} superfamily signaling FASEB J, December 1, 1999; 13(15): 2105 - 2124. [Abstract] [Full Text]
|
|
|
|
|
|
A. Nishihara, J.-i. Hanai, T. Imamura, K. Miyazono, and M. Kawabata E1A Inhibits Transforming Growth Factor-beta Signaling through Binding to Smad Proteins J. Biol. Chem., October 1, 1999; 274(40): 28716 - 28723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Shen, P. P.-c. Hu, N. T. Liberati, M. B. Datto, J. P. Frederick, and X.-F. Wang TGF-beta -induced Phosphorylation of Smad3 Regulates Its Interaction with Coactivator p300/CREB-binding Protein Mol. Biol. Cell, December 1, 1998; 9(12): 3309 - 3319. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Kurokawa, K. Mitani, Y. Imai, S. Ogawa, Y. Yazaki, and H. Hirai The t(3;21) Fusion Product, AML1/Evi-1, Interacts With Smad3 and Blocks Transforming Growth Factor-beta -Mediated Growth Inhibition of Myeloid Cells Blood, December 1, 1998; 92(11): 4003 - 4012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. P.-c. Hu, M. B. Datto, and X.-f. Wang Molecular Mechanisms of Transforming Growth Factor-{beta} Signaling Endocr. Rev., June 1, 1998; 19(3): 349 - 363. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. B. Dallas, I. W. Cheney, D.-W. Liao, V. Bowrin, W. Byam, S. Pacchione, R. Kobayashi, P. Yaciuk, and E. Moran p300/CREB Binding Protein-Related Protein p270 Is a Component of Mammalian SWI/SNF Complexes Mol. Cell. Biol., June 1, 1998; 18(6): 3596 - 3603. [Abstract] [Full Text]
|
|
